Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000019020
JPRN-UMIN000019020Completed未知

Investigation oflipid-improving and pleiotrophic effects of pitavastatin - Investigation oflipid-improving and pleiotrophic effects of pitavastatin

Fukui University School of Medical Science0 sites60 target enrollmentStarted: September 15, 2015Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

  1. The pitavastatin treatment decreased LDL-C, sd-LDL-C, and CETP levels by 39%, 42%, and 23%, respectively. 2) Despite the absence of a significant association between CETP and LDL-C levels at baseline, baseline CETP levels and its percentage change were an independent positive determinant for the changes observed in LDL-C and sd-LDL-C levels.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1) Patients with severe hepatic dysfunction 2) Patients with severe chronic renal dysfunction(serum Cr of 2.0 mg/dL or more) 3) Patients with severe cerebral vascular disease 4)Patients are judged as being inappropriate for this study by their own doctors 5) Patients are judged as being inappropriate for this study by investigators

Investigators

Sponsor
Fukui University School of Medical Science

Similar Trials

Completed
Not Applicable
Effects of aggressive lipid-lowering therapy on atherosclerosis and multi-lipoprotein profiling in patients with coronary artery diseasePatients with coronary artery disease
JPRN-UMIN000002507agoya University Graduate School of Medicine100
Unknown
Not Applicable
Pitavastatin on Carotid Intima-media ThicknessCarotid Artery DiseasesHyperlipidemia
NCT00711919Kyoto Prefectural University of Medicine300
Completed
Not Applicable
Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary SyndromeAcute coronary syndrome
JPRN-UMIN000002742Department of Cardiology, Tokyo Women's Medical University3,000
Completed
Not Applicable
Effects of Pitavastatin on Insulin Sensitivity and Liver FatFatty Liver, NonalcoholicObesity
NCT02290106Massachusetts General Hospital50
Unknown
Phase 4
Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)AtherosclerosisDyslipidemia
NCT00712049Medical University of Vienna200